CD8A and myeloid sarcoma: Using our recently published time-lapse co-culture model [6], we compared the motility of CD8+ T lymphocytes from healthy donors and MS patients in co-culture with untreated or IL-27-treated astrocytes (Fig. 5A, Additional files 3 and 4: movies 1–2).